01 1Cipla
01 1SIPONIMOD ADIPIC ACID
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-01-06
Pay. Date : 2022-11-25
DMF Number : 37520
Submission : 2022-11-17
Status : Active
Type : II
20
Cipla Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is SIPONIMOD ADIPIC ACID, with a corresponding US DMF Number 37520.
Remarkably, this DMF maintains an Active status since its submission on November 17, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 06, 2023, and payment made on November 25, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
